6MCS
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-003
Summary for 6MCS
Entry DOI | 10.2210/pdb6mcs/pdb |
Descriptor | Protease, (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]carbamate (3 entities in total) |
Functional Keywords | hiv-1, inhibitor, viral protein |
Biological source | Human immunodeficiency virus 1 |
Total number of polymer chains | 1 |
Total formula weight | 11519.61 |
Authors | Bulut, H.,Hayashi, H.,Hattori, S.I.,Aoki, M.,Das, D.,Ghosh, A.K.,Mitsuya, H. (deposition date: 2018-09-02, release date: 2019-04-24, Last modification date: 2023-10-11) |
Primary citation | Hattori, S.I.,Hayashi, H.,Bulut, H.,Rao, K.V.,Nyalapatla, P.R.,Hasegawa, K.,Aoki, M.,Ghosh, A.K.,Mitsuya, H. Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants. Antimicrob.Agents Chemother., 63:-, 2019 Cited by PubMed: 30962341DOI: 10.1128/AAC.02635-18 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.52 Å) |
Structure validation
Download full validation report